Member Info for Prion25

Good news but Ceres conspicuous by its absence?

Read Scancell RNS Starmer making a lot of beneficial noises on innovation clinical trials and cancer treatments within NHS .Bodes well

Read the Scancell RNS and what Starmer says about speeding up innovation and clinical trials within the NHS bodes well

trump received regeneron’s monoclonal ****tail whilst it was still in clinical trials he received it on compassionate grounds the benefits of research saved his life and the big idiot might need avacta one day

Very impressive makes the David Millivolt somewhat goofy

The funding is just a massive endorsement of the kit and great value for money which includes the machine staff costsand significant savings to NHS through prevention of hearing loss The cost of a Genedrive MT-RNR1 ID kit test for detecting a genetic variant associated with hearing loss is around £130.08, which includes additional costs like machine purchase, printing, controls, warranty, and staff costs, though the kit itself costs £100 excluding VAT. That is the cost per test and potentially a huge global market awaits

Hopefully Shell will light the blue touch paper Ceres SOEC excels in industrial scale applications and has greater efficiency more cost effective electrodes and larger scale hydrogen production when compared to Bosch PEMs What's not to like if they are serious about scaling up green hydrogen production to advance decarbonization

Https://www.reuters.com/business/healthcare-pharmaceuticals/trump-turbulence-stalls-large-pharma-biotech-deals-bankers-say-2025-03-26/

Trump attacking big Pharma and patents what the hell next ?

Thanks good article Constructive News . Bosch are pulling out of fuel cell stacks not electrolysers (PEM) which your title states

Thanks D-Geeman for the link for the summitcast

Very interesting especial the IND for ALS disease Neuroinflammation treatment seems to be novel approach and I get a feeling they may be onto something here After many years ignoring my small holding in this company it has suddenly become a very worthwhile punt imo

Https://www.gov.scot/news/improving-health-through-innovation/

Stocksaint

The ANIA pathway will test over 3000 newborns over 18months and the this will be rolled out to the other 14 territorial regions in Scotland NHS so the expectation is far greater

@ Lostapound

Thanks for the clarification

Patient 1 doing well no adverse effects is great news what we really need to know is there a signal a reduction in FLT 3 malignant cells I assume there must be for them to proceed to P2 ?

Milestone achieved great news indeed saving lives improving patient outcomes saving resources with a rapid POC and no specialist training required it will be transformation in Acute stroke management Everything Wes Streeting is aspiring too Well done Genedrive

Https://www.fiercebiotech.com/biotech/after-900m-restructure-takedas-oncology-leaders-prioritize-3-modalities-and-warn-against

looks like Takeda scaling back from cell therapies to in favour of ADC s

Cost saving tech and innovation is paramount to justify this massive abolishment of NHS England

When I go to GP and ask for a fully validated PSA test I am advised against it because you cannot trust a negative it may be false and you may still be PC sufferer or a positive could be a false positive that may require a very unpleasant unnecessary biopsy . So I demand to have a PSA and the option of DRE and hope for the best but still there is apprehension with men of my age with this terrible disease All doctors have opinions and they may rely on symptoms and genetics rather than the useless PSA and of course there is the Transform project which will use MRI and other biomarkers and real world data and AI to hopefully to detect PC in men without symptoms which is good news .But this could be at least 5 years away not good for the older Cohort like me So I welcome the PSE which has been validated against albeit a small study against the PSA Moreover like Transform real word data with AI and a private company with superb science and Ross at the helm which I believe will be transformational. I hear now KS is doing a Trump and abolishing NHS England more wrangling within NHS then before any progress ?

Website down again

Just at this late hour listened to the presentation CC was fantastic and inspiring compared with mumbling dead pan questioning As Trump would say she holds all the cards and a great deal will be forthcoming Targeting difficult to treat salivary gland cancer where there is no other available treatment was a master stroke and then successfully providing the AVA600 data of meaning full PFS efficacy and low toxicity must be have impressed all those present and her excitement going forward to eventually to tackle lung cancer The use of Tempus /AI strategy was another great move to support the precision platform and FAP dissemination Still much more to come with AVA6103 I Know and lots Strategic conversations going on which we are not privy too